Markers of systemic inflammation predict survival in patients with advanced renal cell cancer.
about
Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-AnalysisInflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patientsAssociation of post-treatment hypoalbuminemia and survival in Chinese patients with metastatic renal cell carcinoma.Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer.Prognostic value of PLR in various cancers: a meta-analysis.Prognostic role of NLR in urinary cancers: a meta-analysisPrognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysisThe association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.Novel immunological and nutritional-based prognostic index for gastric cancer.Circulating Concentrations of Vitamin B6 and Kidney Cancer Prognosis: A Prospective Case-Cohort StudyPrognostic Significance of Preoperative Albumin-Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma.Preoperative Plasma Fibrinogen Level Represents an Independent Prognostic Factor in a Chinese Cohort of Patients with Upper Tract Urothelial Carcinoma.Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapyIncreased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancerNutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinomaA Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RTSystemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma.Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis.Preoperative Lymphocyte-Monocyte Ratio Ameliorates the Accuracy of Differential Diagnosis in Non-Metastatic Infiltrative Renal Masses.Net risk reclassification p values: valid or misleading?Perspectives in anaesthesia for cancer surgery.Platelet distribution width as a prognostic factor in patients with COPD - pilot study.Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysisDeterminants and prognostic implications of malignant ascites in metastatic papillary renal cancer.Pre-treatment neutrophil to lymphocyte ratio as a predictive marker for pathological response to preoperative chemoradiotherapy in pancreatic cancer.Serum inflammatory markers and colorectal cancer risk and survival.Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma.Prognostic value of a systemic inflammatory response index in metastatic renal cell carcinoma and construction of a predictive model.Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy.Neuropeptide Levels as well as Neprilysin Activity Decrease in Renal Cell Carcinoma.Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib.Prognostic value of pretreatment albumin-globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection.Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer.Cancer and systemic inflammation: stage the tumour and stage the hostThe clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis.The Prognostic Value of Platelet-to-Lymphocyte Ratio in Urological Cancers: A Meta-Analysis.Interaction among smoking status, single nucleotide polymorphisms and markers of systemic inflammation in healthy individuals.Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer.The Prediction Value of the Systemic Inflammation Score for Oral Cavity Squamous Cell Carcinoma.Combined analysis of the pre- and postoperative neutrophil-lymphocyte ratio predicts the outcomes of patients with gastric cancer.
P2860
Q26786160-CB47DD00-60E1-452D-9866-6351CE7C83D2Q27009534-9A22959C-D531-4CD1-8B04-1F0F05AE3273Q33702779-7C3C6567-5451-44F1-A2CB-ECF3441C87B7Q33810288-3F6FF5C9-08CB-45F8-AEC4-410C9452F21CQ33812584-B8BA86DD-4C64-4AAC-B60E-633F2A768A24Q35124106-6C7AF7F7-3F4D-4FC3-8BE5-C9018FD3D36DQ35332425-B419AFA6-A0AF-4514-890F-04C75FB4DBC1Q35625163-63120613-8D6E-481D-993D-3B0F040F5060Q35625425-89326289-84E2-43CC-BE3D-FBF0CF9FB6FEQ35823156-3BB77501-844B-427D-86D0-AF19337E06E2Q35872670-4DD67FD6-18AB-4F15-A250-2B93A3CCA280Q35940860-945BB54B-0AB3-4EE0-B0CB-7D6C39C8611FQ36028749-7D0FE255-E217-440E-BB8B-6EB3656704DCQ36069609-AF6808C8-69A6-47B0-9C3B-DBD4C0284998Q36074171-A7AEA97E-0E94-431F-A8FF-A20FA7E1A056Q36082978-637145CC-0DB4-4F2E-A671-2E206F1E24A6Q36287097-23FF8647-1D9F-4BB8-B2B8-FA8469010F25Q37391865-63F6F03C-F1AA-4177-A9B8-C1C99D6E6B0CQ37622164-2B3353FF-EEBC-4850-9929-577CA860A47BQ37696697-31CBB04E-A716-4759-9095-5D488495AA0EQ38146832-7A2F72AC-2637-45E4-96A1-117FE3239027Q38621357-B385C463-06F8-4950-8116-0EA38A301584Q38650153-56091946-35C8-41B1-88D2-71D9B458D4CDQ39133362-9808E149-065C-408A-9A27-0BA153888D5DQ39985070-00C1D242-47C3-4648-8B4B-D2331CD251EEQ40258867-5B2EE009-8AB6-4C61-BBCF-9B857F5D8050Q40549268-E23A577A-8CDC-4092-ADFA-808827A2C362Q41592612-052CD4F3-F200-4C8F-8B86-744EA76490D0Q41624982-5BC4A927-1618-4E1B-9F7E-B421EAFE6673Q41826076-C10B9210-2062-4109-8E04-0C458D74D388Q42128311-6DA9386C-3C92-40FD-B368-D2CE83F80B93Q42290661-CBD0C17B-00E1-4291-98E3-4B3824E6C5B7Q42378488-06D63664-AB33-452A-8755-F136AA8A5D2BQ42546214-6D8BB938-CBE0-4814-9442-15EBC1F3345BQ47107452-3CBD2EA1-D899-488D-9723-D6C44CC13F2FQ47108127-15287832-1DD7-4812-8C51-A66044F673B6Q47400167-9348A46B-7E31-41FE-9D86-F9C9B2E8A8C7Q48336799-5A1DC275-C62D-40E9-9DE0-5E5D6840C82EQ50039906-8F0272E3-5134-4EE7-8523-E9DC073F6615Q50060426-53F2A1B1-5452-4C6A-944B-5977B42BA4D7
P2860
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Markers of systemic inflammati ...... th advanced renal cell cancer.
@en
Markers of systemic inflammati ...... th advanced renal cell cancer.
@nl
type
label
Markers of systemic inflammati ...... th advanced renal cell cancer.
@en
Markers of systemic inflammati ...... th advanced renal cell cancer.
@nl
prefLabel
Markers of systemic inflammati ...... th advanced renal cell cancer.
@en
Markers of systemic inflammati ...... th advanced renal cell cancer.
@nl
P2093
P2860
P50
P356
P1476
Markers of systemic inflammati ...... ith advanced renal cell cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2013.300
P407
P577
2013-06-18T00:00:00Z